Rulin Zhao Selected Research

Rulin Zhao Research Topics

5	Neoplasms (Cancer) 01/2022 - 03/2004
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2020
2	Pancreatitis 01/2021 - 10/2020
2	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 02/2019
1	Adenocarcinoma 01/2022
1	Bites and Stings (Sting) 08/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Diarrhea 01/2018
1	Infections 01/2018
1	Cognitive Dysfunction 03/2017
1	Schizophrenia (Dementia Praecox) 03/2017
1	Experimental Arthritis 10/2015
1	Obesity 09/2014
1	Hypercholesterolemia 05/2008
1	Muscular Diseases (Myopathy) 05/2008
1	Myotoxicity 05/2008
1	Rhabdomyolysis 05/2008
1	Weight Gain 06/2007

2	ProdrugsIBA 10/2015 - 09/2014
1	RNA (Ribonucleic Acid)IBA 01/2022
1	NucleosidesIBA 08/2021
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	insulin-like growth factor binding protein-related protein 1IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 10/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 02/2019
1	BMS-933043IBA 03/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2017
1	EstersIBA 09/2014
1	EthersIBA 09/2014
1	Phosphates (Orthophosphate)IBA 09/2014
1	thienopyrimidinoneIBA 09/2014
1	Coenzyme A (CoA)IBA 05/2008
1	LipidsIBA 05/2008
1	AcidsIBA 05/2008
1	Oxidoreductases (Dehydrogenase)IBA 05/2008
1	7- (4- (4- fluorophenyl)- 6- isopropyl- 2- (methyl(1- methyl- 1H- 1,2,4- triazol- 5- yl)amino)pyrimidin- 5- yl)- 3,5- dihydroxyhept- 6- enoic acidIBA 05/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008
1	Triglycerides (Triacylglycerol)IBA 06/2007
1	Glucose (Dextrose)FDA LinkGeneric 06/2007
1	CholesterolIBA 06/2007
1	Antineoplastic Agents (Antineoplastics)IBA 03/2004
1	alvocidib (flavopiridol)IBA 03/2004

1	Immunotherapy 01/2022
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Renal Dialysis (Hemodialysis) 01/2021
1	Therapeutics 01/2018